Exagamglogene Autotemcel: First Approval.
Hoy SM.
Mol Diagn Ther. 2024 Mar;28(2):133-139. doi: 10.1007/s40291-024-00696-z. Epub 2024 Jan 17.
Sickle Cell Disease.
Bender MA, Carlberg K.
2003 Sep 15 [updated 2025 Feb 13]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025.
Sickle Cell Trait.
Ashorobi D, Ramsey A, Killeen RB, Bhatt R.
2024 Feb 25. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–.
Falsely elevated hemoglobin A1c due to S-beta+-thalassemia interference in Bio-Rad Variant II Turbo HbA1c assay.
Zhu Y, Williams LM.
Clin Chim Acta. 2009 Nov;409(1-2):18-20. doi: 10.1016/j.cca.2009.08.009. Epub 2009 Aug 19.
Hb S (HBB: c.20A>T) and alpha- and beta-Thalassemia Coinheritance in Iranian Patients.
Azarkeivan A, Cohan N, Niazkar HR, Azizi A, Rad F.
Hemoglobin. 2020 Mar;44(2):109-112. doi: 10.1080/03630269.2020.1757462. Epub 2020 May 6.
Hb S/beta-Thalassemia in the REDS-III Brazil Sickle Cell Disease Cohort: Clinical, Laboratory and Molecular Characteristics.
Belisário AR, Carneiro-Proietti AB, Sabino EC, Araújo A, Loureiro P, Máximo C, Flor-Park MV, Rodrigues DDOW, Ozahata MC, McClure C, Mota RA, Gomes Moura IC, Custer B, Kelly S; Recipient Epidemiology and Donor Evaluation Study (REDS-III) International Component Brazil.
Hemoglobin. 2020 Jan;44(1):1-9. doi: 10.1080/03630269.2020.1731530. Epub 2020 Mar 16.
Compound Heterozygosity of beta-Thalassemia and the Sickle Cell Hemoglobin in Various Populations of Chhattisgarh State, India.
Jha AN, Mishra H, Verma HK, Pandey I, Lakkakula BVKS.
Hemoglobin. 2018 Mar;42(2):84-90. doi: 10.1080/03630269.2018.1483946.
The Spectrum of beta-Thalassemia Mutations in a Population from the Brazilian Amazon.
Silva AN, Cardoso GL, Cunha DA, Diniz IG, Santos SE, Andrade GB, Trindade SM, Cardoso Mdo S, Francês LT, Guerreiro JF.
Hemoglobin. 2016;40(1):20-4. doi: 10.3109/03630269.2015.1083443. Epub 2015 Sep 15.
Stratification of beta(S)beta(+) Compound Heterozygotes Based on L-Glutamine Administration and RDW: Focusing on Disease Severity.
Giannaki A, Georgatzakou HΤ, Fortis SP, Anastasiadi AT, Pavlou EG, Nomikou EG, Drandaki MP, Kotsiafti A, Xydaki A, Fountzoula C, Papageorgiou EG, Tzounakas VL, Kriebardis AG.
Antioxidants (Basel). 2023 Nov 8;12(11):1982. doi: 10.3390/antiox12111982.
In silico analysis of substitution mutations in the beta-globin gene in Turkish population of beta-thalassemia.
Alkilani S, Sevimoglu T.
J Biomol Struct Dyn. 2023;41(23):14028-14035. doi: 10.1080/07391102.2023.2176924. Epub 2023 Feb 8.
